First NDM-positive Salmonella sp. strain identified in the United States

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5957-5958

  Savard, Patrice ^a   Gopinath, Ramya ^b   Zhu, Wenming ^c   Kitchel, Brandon ^c   Rasheed, J Kamile ^c   Tekle, Tsigereda ^d   Roberts, Ava ^d   Ross, Tracy ^d   Razeq, Jafar ^e   Landrum, B Mark ^b   Wilson, Lucy E ^e   Limbago, Brandi ^c   Perl, Trish M ^f   Carroll, Karen C ^d  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Howard County General Hospital   (United States)

^c NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^d DEPARTMENT OF PATHOLOGY   (United States)

^e MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^f Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEMASE; COLISTIN; COTRIMOXAZOLE; IMIPENEM; MEROPENEM; TETRACYCLINE; TIGECYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BRAIN HEMORRHAGE; BROTH DILUTION; CASE REPORT; FEVER; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SEROTYPING; UNITED STATES;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; SEROTYPING; UNITED STATES;

EID: 81555212308     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05719-11     Document Type: Letter

References (9)

1. AB Biodisk. 2010. Etest MBL for in vitro detection of metallo beta-lactamase. AB bioMerieux, Durham, NC. http://www.abbiodisk.com/pdf/pi/ 75001546 .PDF.
2. Brenner, F. W., and A. C. McWhorter-Murlin. 1998. Identification and serotyping of Salmonella. Centers for Disease Control and Prevention, Atlanta, GA.
3. CLSI. 2011. Performance standards for antimicrobial susceptibility testing, 21st informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
4. González-Sanz, R., S. Herrera-Leon, M. de la Fuente, M. Arroyo, and M. A. Echeita. 2009. Emergence of extended-spectrum beta-lactamases and AmpCtype beta-lactamases in human Salmonella isolated in Spain from 2001 to 2005. J. Antimicrob. Chemother. 64:1181-1186.
5. Miriagou, V., et al. 2003. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 47:1297-1300. (Pubitemid 36368588)
6. Moellering, R. C., Jr. 2010. NDM-1-a cause for worldwide concern. N. Engl. J. Med. 363:2377-2379.
7. Revathi, G., K. P. Shannon, P. D. Stapleton, B. K. Jain, and G. L. French. 1998. An outbreak of extended-spectrum, beta-lactamase-producing Salmonella senftenberg in a burns ward. J. Hosp. Infect. 40:295-302. (Pubitemid 28552398)
8. Walsh, T. R., J. Weeks, D. M. Livermore, and M. A. Toleman. 2011. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect. Dis. 11(5):355-362.
9. Yong, D., et al. 2009. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother. 53:5046-5054.